Following the 2006 mid-term elections, changes in the composition of the U.S. Congress have raised the question of how previously-proposed legislation concerning intellectual property (IP) rights and legal protections will be addressed. More...

A pair of scientists in Great Britain reportedly has developed a means of producing a pharmaceutical used to treat Hepatitis C, which, despite containing modifications at the molecular level of its active constituents, would be equivalent to a brand-name pharmaceutical. If commercialized, the new drug would permit generic pharmaceutical manufacturers to make such a means of treating Hepatitis C dramatically more affordable--especially to those in impoverished nations. More...

Eli Lilly & Company won a federal appeals court ruling on December 26, sustaining its patent on the anti-psychotic drug, Zyprexa. More...